本页面由Tiger Trade Technology Pte. Ltd.提供服务

CRISPR Therapeutics AG

57.99
+2.274.07%
盘后58.010.0200+0.03%19:59 EDT
成交量:180.15万
成交额:1.05亿
市值:55.66亿
市盈率:-8.96
高:59.16
开:57.35
低:57.05
收:55.72
52周最高:78.48
52周最低:33.03
股本:9,598.53万
流通股本:9,053.30万
量比:1.06
换手率:1.99%
股息:- -
股息率:- -
每股收益(TTM):-6.4700
每股收益(LYR):-6.4700
净资产收益率:-30.18%
总资产收益率:-15.76%
市净率:2.90
市盈率(LYR):-8.96

数据加载中...

2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/20

重要事件披露

8-K - Current report
2021/12/07

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/07

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/07

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/07

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/18

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/14

重要事件披露

8-K - Current report
2021/10/12

重要事件披露

8-K - Current report
2021/09/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/08/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/07/29

重要事件披露

8-K - Current report
2021/07/29

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/14

重要事件披露

8-K - Current report
2021/06/11

重要事件披露

8-K - Current report
2021/06/02

重要事件披露

8-K - Current report